Delivery Order SPE2DB25D3012-SPE2DB25FXAHU
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ketorolac 30 mg/mL in vial form, with a ceiling value of $1,339.14. This is a firm fixed price delivery order issued under a competitive, non-set-aside procurement. The order is scheduled for ultimate completion on September 19, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for Ketorolac 30 mg/mL vials with a ceiling value of $2,472.26. This firm fixed-price delivery order represents a non-competitive set-aside contract and carries an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Ketorolac 30 mg/mL vials valued at $1,298.52. This award represents a firm fixed-price delivery order with no set-aside designation, indicating competitive selection among qualified vendors. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. As a child...
- The Defense Logistics Agency awarded a delivery order valued at $1,427.96 to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/mL vials. This contract, awarded on August 28, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 29, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively procured through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/mL vial supply, with a ceiling value of $5,818.80. This competitive award, issued on August 6, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 7, 2025. The product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. As a non-set-aside award, this contract was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Ketorolac 15 mg/ml vials at a firm fixed price ceiling value of $1,476.08. This is an unset-aside, competitively awarded delivery order with an ultimate completion date of September 9, 2025. The product will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $4,423.20 delivery order to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/ml vials on May 30, 2025, with completion scheduled for June 2, 2025. This competitively awarded contract utilizes a firm fixed price structure and is classified as a child contract under a larger vehicle. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ketorolac is a nonsteroidal anti-inflammatory drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/ml vials with a ceiling value of $1,163.76. The order, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, is a firm fixed-price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $1,454.70 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Ketorolac 30 mg/mL vials. This is a firm fixed-price contract with no set-aside designation, reflecting competitive procurement on open terms. The product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. This delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a $1,163.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/mL vial supply on September 22, 2025, with completion targeted for September 23, 2025. This is a non-set-aside, competitively awarded contract with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a single transactional purchase under a larger contract vehicle supporting the federal government's...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FXAHUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ketorolac 30 mg/mL vials with a ceiling value of $2,424.50. This firm fixed-price delivery order, with a completion date of September 19, 2025, was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order fulfills pharmaceutical supply requirements for federal military and healthcare operations through AmerisourceBergen's comprehensive global pharmaceutical support vehicle. Ketorolac, a nonsteroidal anti-inflammatory drug used for pain management, is representative of the company's extensive portfolio of brand-name and generic medications supplied to the Defense Health Agency and other federal healthcare systems. The award demonstrates AmerisourceBergen's continued role as a critical pharmaceutical vendor supporting military medical supply chains through DLA's Troop Support Medical procurement operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 9/18/25 |